The effects of 5-HT1A, 5-HT1B and 5-HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats

This publication has 19 references indexed in Scilit:

• Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5‐hydroxy‐tryptamine (5‐HT_1B/1D) receptors
  British Journal of Pharmacology, 1997
• Detailed mapping of serotonin 5-HT1B and 5-HT1D receptor messenger RNA and ligand binding sites in guinea-pig brain and trigeminal ganglion: clues for function
  Neuroscience, 1997
• Rizatriptan has central antinociceptive effects against durally evoked responses
  European Journal of Pharmacology, 1997
• Direct Evidence for Central Sites of Action of Zolmitriptan (311C90)
  Cephalalgia, 1997
• Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine ?
  Pain, 1996
• The inhibitory effect of 8-OH-DPAT on the firing activity of dorsal raphe serotoninergic neurons in rats is attenuated by lesion of the frontal cortex
  Neuropharmacology, 1994
• A comparative autoradiographic study of 5-HT1D binding sites in human and guinea-pig brain using different radioligands
  Molecular Brain Research, 1994
• Evidence for the presence of 5-HT1B receptor messenger RNA in neurons of the rat trigeminal ganglia
  European Journal of Pharmacology: Molecular Pharmacology, 1992
• Mode of action of the anti-migraine drug sumatriptan
  Trends in Pharmacological Sciences, 1991
• Cardiovascular Response to 8-Hydroxy-2-(di-n-Propylamino) Tetralin (8-OH-DPAT) in the Rat: Site of Action and Pharmacological Analysis
  Journal of Cardiovascular Pharmacology, 1987